49 related articles for article (PubMed ID: 22848294)
1. Diagnosis and conservative treatment of a rare case of femoral intraosseous arteriovenous malformation in a patient with polyostotic fibrous dysplasia: A case report.
Ohshika S; Yanagisawa M; Tsushima F; Ishibashi Y
Mol Clin Oncol; 2019 Jun; 10(6):587-591. PubMed ID: 31086668
[TBL] [Abstract][Full Text] [Related]
2. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.
Rotman M; Hamdy NAT; Appelman-Dijkstra NM
Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134
[TBL] [Abstract][Full Text] [Related]
3. A Rare Cause of Shoulder Pain: Monostotic Fibrous Dysplasia.
Kelle B; Polat Kelle A; Eren Erdoğan K; Kozanoğlu E
Arch Rheumatol; 2016 Jun; 31(2):184-187. PubMed ID: 29900939
[TBL] [Abstract][Full Text] [Related]
4. [Fibrous dysplasia: overview].
Akasbi N; Abourazzak FE; Talbi S; Tahiri L; Harzy T
Pan Afr Med J; 2015; 21():21. PubMed ID: 26401215
[TBL] [Abstract][Full Text] [Related]
5. Polyostotic fibrous dysplasia involving the thoracic spine with myelopathy: case report and review of the literature.
Wu FL; Liu ZJ; Liu XG; Yang SM; Jiang L; Wei F; Yu M
Spine J; 2014 Jan; 14(1):e11-5. PubMed ID: 24094990
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of oral alendronate therapy in an elderly patient with polyostotic fibrous dysplasia: A case report.
Li GD; Ogose A; Hotta T; Kawashima H; Ariizumi T; Xu Y; Endo N
Oncol Lett; 2011 Nov; 2(6):1239-1242. PubMed ID: 22848294
[TBL] [Abstract][Full Text] [Related]
7. Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.
Kitagawa Y; Tamai K; Ito H
J Orthop Sci; 2004; 9(5):521-5. PubMed ID: 15449129
[TBL] [Abstract][Full Text] [Related]
8. Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Jayaraman M; Karikumar K; Verma A; Modi KD
Am J Orthop (Belle Mead NJ); 2011 Mar; 40(3):E48-50. PubMed ID: 21720608
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
[TBL] [Abstract][Full Text] [Related]
11. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
12. Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report.
Aragão AL; Silva IN
Int J Pediatr Endocrinol; 2010; 2010():432060. PubMed ID: 20976302
[TBL] [Abstract][Full Text] [Related]
13. Medical therapy in adults with fibrous dysplasia of bone.
Chapurlat RD
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P114-9. PubMed ID: 17228999
[TBL] [Abstract][Full Text] [Related]
14. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone.
Collins MT; Kushner H; Reynolds JC; Chebli C; Kelly MH; Gupta A; Brillante B; Leet AI; Riminucci M; Robey PG; Bianco P; Wientroub S; Chen CC
J Bone Miner Res; 2005 Feb; 20(2):219-26. PubMed ID: 15647815
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
